Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

oritavancin MeSH Supplementary Concept Data 2026


MeSH Supplementary
oritavancin
Unique ID
C100708
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C100708
Entry Term(s)
(4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin
LY 333328
LY-333328
LY333328
Orbactiv
Pharm Action
Anti-Bacterial Agents
Registry Numbers
PUG62FRZ2E
Previous Indexing
*ANTI-BACTERIAL AGENTS (1996-2005)
*GLYCOPEPTIDES (2006-2018)
Heading Mapped to
Vancomycin / analogs & derivatives
*Lipoglycopeptides
Frequency
241
Source
J Antibiot (Tokyo) 1996 Jun;49(6):575-81
Date Introduced
1996/09/04
Last Updated
2022/07/22
oritavancin Preferred
LY 333328 Narrower
Orbactiv Narrower
page delivered in 0.004s